Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study)
- PMID: 22980963
- PMCID: PMC3511639
- DOI: 10.1016/j.amjcard.2012.07.044
Risk factors for coronary artery calcium among patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study)
Abstract
Cardiovascular disease is the leading cause of death in patients with chronic kidney disease (CKD). We examined the cross-sectional association between novel risk factors and coronary artery calcium (CAC) measured using electron beam computed tomography or multidetector computed tomography among 2,018 patients with CKD. Using the total Agatston scores, the participants were classified as having no (0), moderate (>0-100), or high (>100) CAC. After adjustment for age, gender, race, study sites, cigarette smoking, previous cardiovascular disease, hypertension, and diabetes, the use of lipid-lowering drugs, body mass index, waist circumference, and cystatin C, several novel risk factors were significantly associated with high CAC. For example, the odds ratios of high CAC associated with 1 SD greater level of risk factors were 1.20 (95% confidence interval 1.04 to 1.38) for serum calcium, 1.21 (95% confidence interval 1.04 to 1.41) for serum phosphate, 0.83 (95% confidence interval 0.71 to 0.97) for log (total parathyroid hormone), 1.21 (95% confidence interval 1.03 to 1.43) for log (homeostasis model assessment-insulin resistance), and 1.23 (95% confidence interval 1.04 to 1.45) for hemoglobin A1c. Additionally, the multivariate-adjusted odds ratio for 1 SD greater level of cystatin C was 1.31 (95% confidence interval 1.14 to 1.50). Serum high-sensitive C-reactive protein, interleukin-6, tumor necrosis factor-α, and homocysteine were not statistically significantly associated with high CAC. In conclusion, these data indicate that abnormal calcium and phosphate metabolism, insulin resistance, and declining kidney function are associated with the prevalence of high CAC, independent of the traditional risk factors in patients with CKD. Additional studies are warranted to examine the causal effect of these risk factors on CAC in patients with CKD.
Copyright © 2012 Elsevier Inc. All rights reserved.
Conflict of interest statement
Similar articles
-
Risk factors for progression of coronary artery calcification in patients with chronic kidney disease: The CRIC study.Atherosclerosis. 2018 Apr;271:53-60. doi: 10.1016/j.atherosclerosis.2018.02.009. Epub 2018 Feb 10. Atherosclerosis. 2018. PMID: 29459266 Free PMC article.
-
Relation of a coronary artery calcium score higher than 400 to coronary stenoses detected using multidetector computed tomography and to traditional cardiovascular risk factors.Am J Cardiol. 2008 May 15;101(10):1444-7. doi: 10.1016/j.amjcard.2008.01.022. Epub 2008 Mar 17. Am J Cardiol. 2008. PMID: 18471456
-
Estimated kidney function based on serum cystatin C and risk of subsequent coronary artery calcium in young and middle-aged adults with preserved kidney function: results from the CARDIA study.Am J Epidemiol. 2013 Aug 1;178(3):410-7. doi: 10.1093/aje/kws581. Epub 2013 Jun 27. Am J Epidemiol. 2013. PMID: 23813702 Free PMC article.
-
Indexes of kidney function and coronary artery and abdominal aortic calcium (from the Framingham Offspring Study).Am J Cardiol. 2008 Aug 15;102(4):440-3. doi: 10.1016/j.amjcard.2008.04.007. Epub 2008 May 22. Am J Cardiol. 2008. PMID: 18678302 Free PMC article.
-
Comprehensive coronary risk determination in primary prevention: an imaging and clinical based definition combining computed tomographic coronary artery calcium score and national cholesterol education program risk score.Int J Cardiol. 2006 Jun 16;110(2):129-36. doi: 10.1016/j.ijcard.2005.09.009. Epub 2005 Nov 21. Int J Cardiol. 2006. PMID: 16303191 Review.
Cited by
-
Envelope method with ignorable missing data.Electron J Stat. 2021;15(2):4420-4461. doi: 10.1214/21-ejs1881. Epub 2021 Sep 14. Electron J Stat. 2021. PMID: 37842008 Free PMC article.
-
Extracellular Fluid Excess Is Significantly Associated With Coronary Artery Calcification in Patients With Chronic Kidney Disease.J Am Heart Assoc. 2018 Jun 30;7(13):e008935. doi: 10.1161/JAHA.118.008935. J Am Heart Assoc. 2018. PMID: 29960990 Free PMC article.
-
Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study.Am J Kidney Dis. 2025 Jan;85(1):67-77.e1. doi: 10.1053/j.ajkd.2024.06.018. Epub 2024 Aug 16. Am J Kidney Dis. 2025. PMID: 39154888
-
A review of the effect of diet on cardiovascular calcification.Int J Mol Sci. 2015 Apr 21;16(4):8861-83. doi: 10.3390/ijms16048861. Int J Mol Sci. 2015. PMID: 25906474 Free PMC article. Review.
-
Correlation of Vascular Calcification With Frailty and Quality of Life in Chronic Kidney Disease Stage 4 and 5 Non-dialysis Patients.Cureus. 2025 Feb 24;17(2):e79549. doi: 10.7759/cureus.79549. eCollection 2025 Feb. Cureus. 2025. PMID: 40144440 Free PMC article.
References
-
- Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305. - PubMed
-
- Shlipak MG, Fried LF, Cushman M, Manolio TA, Peterson D, Stehman-Breen C, Bleyer A, Newman A, Siscovick D, Psaty B. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA. 2005;293:1737–1745. - PubMed
-
- Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Society Nephrol. 2002;13:745–753. - PubMed
-
- Greenland P, Bonow RO, Brundage BH, Budoff MJ, Eisenberg MJ, Grundy SM, Lauer MS, Post WS, Raggi P, Redberg RF, Rodgers GP, Shaw LJ, Taylor AJ, Weintraub WS, Harrington RA, Abrams J, Anderson JL, Bates ER, Grines CL, Hlatky MA, Lichtenberg RC, Lindner JR, Pohost GM, Schofield RS, Shubrooks SJ, Jr, Stein JH, Tracy CM, Vogel RA, Wesley DJ. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force. Circulation. 2007;115:402–426. - PubMed
MeSH terms
Substances
Grants and funding
- U01 DK061028/DK/NIDDK NIH HHS/United States
- UL1 RR024989/RR/NCRR NIH HHS/United States
- R01 DK071224/DK/NIDDK NIH HHS/United States
- R01 DK072231/DK/NIDDK NIH HHS/United States
- K24 DK002651/DK/NIDDK NIH HHS/United States
- U01 DK060980/DK/NIDDK NIH HHS/United States
- U01 DK060963/DK/NIDDK NIH HHS/United States
- U01 DK060990/DK/NIDDK NIH HHS/United States
- M01 RR000042/RR/NCRR NIH HHS/United States
- R01 DK074615/DK/NIDDK NIH HHS/United States
- UL1 RR024986/RR/NCRR NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- U01 DK060984/DK/NIDDK NIH HHS/United States
- U01 DK061021/DK/NIDDK NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- R56 DK072231/DK/NIDDK NIH HHS/United States
- U54 GM104940/GM/NIGMS NIH HHS/United States
- M01 RR013987/RR/NCRR NIH HHS/United States
- M01 RR016500/RR/NCRR NIH HHS/United States
- U01 DK060902/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials